The BMMNC-mediated improvement in cardiac function of OMI mice was also affected by treatment with pegvisomant (Figure S7), suggesting that GH in BMMNC might have the therapeutic effects on heart failure caused by various etiologies. This evidence concerns the gene GH1 and heart failure.